We are live on ! Find out more
WFM

Wilmington Funds Management Portfolio holdings

AUM $988M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.48%
1 Year Est. Return
+26.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$988M
AUM Growth
+$67.7M
Cap. Flow
+$35.7M
Cap. Flow %
3.61%
Top 10 Hldgs %
10.81%
Holding
873
New
103
Increased
253
Reduced
220
Closed
127

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.38M
2
AGN
Allergan Inc
AGN
+$5.74M
3
OII icon
Oceaneering
OII
+$4.45M
4
FRX
FOREST LABORATORIES INC
FRX
+$3.94M
5
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$3.61M

Top Sells

Rank Stock Value
1
CTXS
Citrix Systems Inc
CTXS
+$5.03M
2
XOM icon
ExxonMobil
XOM
+$4.42M
3
GE icon
GE Aerospace
GE
+$3.28M
4
CVX icon
Chevron
CVX
+$2.84M
5
HLF icon
Herbalife
HLF
+$2.82M

Sector Composition

Rank Sector Weight
1 Industrials 15.33%
2 Consumer Discretionary 12.29%
3 Healthcare 11.76%
4 Technology 11.66%
5 Real Estate 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HSNI
326
DELISTED
HSN, Inc.
HSNI
$568K 0.06%
9,590
– –
ZTS icon
327
Zoetis
ZTS
$32.7B
$567K 0.06%
17,581
-1,657
-9% -$50.8K
WEX icon
328
WEX
WEX
$6.42B
$564K 0.06%
5,377
– –
MS icon
329
Morgan Stanley
MS
$319B
$562K 0.06%
17,396
-13,300
-43% -$410K
PKOH icon
330
Park-Ohio Holdings
PKOH
$550M
$562K 0.06%
9,669
-1,540
-14% -$87K
SONC
331
DELISTED
Sonic Corp
SONC
$561K 0.06%
25,402
– –
NVDA icon
332
NVIDIA
NVDA
$4.6T
$558K 0.06%
1,203,200
+688,000
+134% +$321K
RYL
333
DELISTED
RYLAND GROUP INC
RYL
$553K 0.06%
14,022
-2,550
-15% -$97.9K
IDIX
334
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
$553K 0.06%
22,956
+7,500
+49% +$78.2K
MNRO icon
335
Monro
MNRO
$414M
$552K 0.06%
10,369
– –
IP icon
336
International Paper
IP
$22.6B
$547K 0.06%
11,607
-107
-0.9% -$4.69K
DAL icon
337
Delta Air Lines
DAL
$56.7B
$543K 0.06%
14,020
-12,976
-48% -$490K
HEI icon
338
HEICO Corp
HEI
$49.6B
$540K 0.05%
25,393
– –
DXPE icon
339
DXP Enterprises
DXPE
$2.3B
$539K 0.05%
7,137
+400
+6% +$34.6K
DCT
340
DELISTED
DCT Industrial Trust Inc.
DCT
$539K 0.05%
16,426
+2,250
+16% +$71K
PPS
341
DELISTED
Post Properties
PPS
$535K 0.05%
10,000
– –
HOG icon
342
Harley-Davidson
HOG
$2.61B
$534K 0.05%
7,650
+1,900
+33% +$134K
NCI
343
DELISTED
Navigant Consulting, Inc.
NCI
$534K 0.05%
30,588
– –
EQT icon
344
EQT Corp
EQT
$32.9B
$529K 0.05%
9,093
+2,755
+43% +$158K
MTZ icon
345
MasTec
MTZ
$22.7B
$527K 0.05%
17,088
– –
CNC icon
346
Centene
CNC
$30.5B
$525K 0.05%
27,800
-13,528
-33% -$232K
KOP icon
347
Koppers
KOP
$946M
$523K 0.05%
13,674
– –
RFMD
348
DELISTED
RF MICRO DEVICES INC
RFMD
$523K 0.05%
54,510
+27,860
+105% +$248K
SHO icon
349
Sunstone Hotel Investors
SHO
$2.19B
$520K 0.05%
34,824
– –
CXO
350
DELISTED
CONCHO RESOURCES INC.
CXO
$517K 0.05%
3,580
+1,200
+50% +$159K
12 13
14
15 16

Similar funds

SCM
Stux Capital Management New York $766M AUM 28.03% 1-Year Est. Return
MIU
Man Investments (UK) London, United Kingdom $1.29B AUM 31.85% 1-Year Est. Return
SR
Swiss Reinsurance Zurich, Switzerland $664M AUM 11.24% 1-Year Est. Return
CH
Cavalane Holdings Sydney, Australia $558M AUM
WTIM
Wilmington Trust Investment Management Wilmington, Delaware $492M AUM 25.19% 1-Year Est. Return
FOAM
Five Oceans Asset Management Sydney, Australia $438M AUM 24.83% 1-Year Est. Return
BII
Baring International Investment London, United Kingdom $1.57B AUM 24.97% 1-Year Est. Return
HGI
Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return

Wilmington Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Wilmington Funds Management held 873 positions worth $988M, up 7.4% from $920M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Wilmington Funds Management deployed $35.7M of net new capital in Q2 2014, opening 103 new positions and adding to 253 existing holdings. Its largest new stake was AstraZeneca: 88,300 shares worth $6.56M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Citrix Systems Inc, an estimated $5.03M trimmed.

  • Wilmington Funds Management's largest Q2 2014 buy was AstraZeneca: 88,300 shares worth $6.56M.
  • Wilmington Funds Management added most to Allergan Inc in Q2 2014, an estimated $5.74M increase.
  • Wilmington Funds Management's biggest Q2 2014 reduction was Citrix Systems Inc, cutting an estimated $5.03M.
  • Wilmington Funds Management fully exited Wolfspeed in Q2 2014, selling an estimated $1.9M.
  • Wilmington Funds Management's ten largest holdings make up 11% of its $988M portfolio in Q2 2014.
  • Wilmington Funds Management opened 103 new positions and closed 127 in Q2 2014.
  • Wilmington Funds Management's portfolio value rose 7.4% quarter-over-quarter to $988M.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.